Related Experiment Video
Updated: Feb 8, 2026
04:36
Author Spotlight: Time and Cost-Effective Fibrinogen-PAGE for Fibrinogenolytic Studies
Published on: April 19, 2024
895
von Willebrand factor and fibrinogen
1Department of Molecular and Experimental Medicine, Scripps Research Institute, La Jolla, California 92037.
Current Opinion in Cell Biology
|October 1, 1993
Summary
Understanding von Willebrand factor and fibrinogen advances hemostasis and thrombosis knowledge. This research may lead to new treatments for vascular diseases and bleeding disorders.
Area of Science:
- Biochemistry
- Hematology
- Vascular Biology
Background:
- Von Willebrand factor and fibrinogen are critical proteins in blood clotting.
- Hemostasis and thrombosis are complex processes involving these key factors.
- Disorders of these proteins can lead to serious bleeding or clotting issues.
Purpose of the Study:
- To explore the implications of recent advancements in understanding von Willebrand factor and fibrinogen.
- To connect structural and functional insights to clinical applications in vascular diseases and bleeding disorders.
Main Methods:
- Review of current literature on von Willebrand factor and fibrinogen structure-function relationships.
- Analysis of emerging concepts in hemostasis and thrombosis research.
Main Results:
- New insights into the molecular mechanisms governing hemostasis and thrombosis.
- Identification of potential therapeutic targets and diagnostic markers.
Conclusions:
- Enhanced understanding of von Willebrand factor and fibrinogen is crucial for advancing medicine.
- These findings may pave the way for novel diagnostic and therapeutic strategies for occlusive vascular diseases and bleeding disorders.
More Related Videos
Related Concept Videos
02:16Transcription Factors
82.8K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.8K
04:01Factors Affecting Solubility
37.2K
Compared with pure water, the solubility of an ionic compound is less in aqueous solutions containing a common ion (one also produced by dissolution of the ionic compound). This is an example of a phenomenon known as the common ion effect, which is a consequence of the law of mass action that may be explained using Le Chȃtelier’s principle. Consider the dissolution of silver iodide:
37.2K
02:35Transcription Elongation Factors
14.0K
Transcription elongation is a dynamic process that alters depending upon the sequence heterogeneity of the DNA being transcribed. Hence, it is not surprising that the elongation complex's composition also varies along the way while transcribing a gene.
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
14.0K
01:19Factors Affecting Drug Distribution: Miscellaneous Factors
1.0K
Drug distribution in the human body is a complex process influenced by various individual factors, including age, pregnancy, obesity, diet, body water composition, pH levels, and specific disease conditions.
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
1.0K
03:08Electrolytes: van't Hoff Factor
37.0K
Colligative Properties of Electrolytes
The colligative properties of a solution depend only on the number, not on the identity, of solute species dissolved. The concentration terms in the equations for various colligative properties (freezing point depression, boiling point elevation, osmotic pressure) pertain to all solute species present in the solution. Nonelectrolytes dissolve physically without dissociation or any other accompanying process. Each molecule that dissolves yields one...
The colligative properties of a solution depend only on the number, not on the identity, of solute species dissolved. The concentration terms in the equations for various colligative properties (freezing point depression, boiling point elevation, osmotic pressure) pertain to all solute species present in the solution. Nonelectrolytes dissolve physically without dissociation or any other accompanying process. Each molecule that dissolves yields one...
37.0K
01:18Factors Affecting Protein-Drug Binding: Drug-Related Factors
487
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
487